• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

两例2型糖尿病患者经益生菌治疗成功。

Two cases of type 2 diabetes mellitus successfully treated with probiotics.

作者信息

Cardinali Néstor, Bauman Carlos, Rodriguez Ayala Facundo, Grau Roberto

机构信息

Instituto Cardinali de Nutrición Rosario Argentina.

Facultad de Ciencias Bioquímicas y Farmacéuticas Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) Universidad Nacional de Rosario Rosario Argentina.

出版信息

Clin Case Rep. 2020 Sep 22;8(12):3120-3125. doi: 10.1002/ccr3.3354. eCollection 2020 Dec.

DOI:10.1002/ccr3.3354
PMID:33363892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7752325/
Abstract

The gut microbiota, and particularly probiotic bacteria, has emerged as a promising and novel intervention to fight the looming worldwide diabetes epidemic when combined with the appropriate medication. Herein, we report two cases of patient with type 2 diabetes refractory to conventional therapy that showed notable improvement after probiotic intervention.

摘要

肠道微生物群，尤其是益生菌，在与适当药物联合使用时，已成为应对全球日益逼近的糖尿病流行的一种有前景的新型干预措施。在此，我们报告两例2型糖尿病患者，他们对传统治疗无效，但在接受益生菌干预后有显著改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a40f/7752325/abcb9f08bfd0/CCR3-8-3120-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a40f/7752325/04b4cedc3997/CCR3-8-3120-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a40f/7752325/abcb9f08bfd0/CCR3-8-3120-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a40f/7752325/04b4cedc3997/CCR3-8-3120-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a40f/7752325/abcb9f08bfd0/CCR3-8-3120-g002.jpg

相似文献

1
Two cases of type 2 diabetes mellitus successfully treated with probiotics.两例2型糖尿病患者经益生菌治疗成功。
Clin Case Rep. 2020 Sep 22;8(12):3120-3125. doi: 10.1002/ccr3.3354. eCollection 2020 Dec.
2
Adjuvant Probiotics of subsp. AP-32, MH-68, and subsp. CP-9 Attenuate Glycemic Levels and Inflammatory Cytokines in Patients With Type 1 Diabetes Mellitus.亚亚种 AP-32、MH-68 和 CP-9 的益生菌辅助治疗可降低 1 型糖尿病患者的血糖水平和炎症细胞因子。
Front Endocrinol (Lausanne). 2022 Mar 1;13:754401. doi: 10.3389/fendo.2022.754401. eCollection 2022.
3
Probiotic supplements alleviate gestational diabetes mellitus by restoring the diversity of gut microbiota: a study based on 16S rRNA sequencing.益生菌补充剂通过恢复肠道微生物群落的多样性来缓解妊娠糖尿病：基于 16S rRNA 测序的研究。
J Microbiol. 2021 Sep;59(9):827-839. doi: 10.1007/s12275-021-1094-8. Epub 2021 Aug 12.
4
Gut-targeted therapies for type 2 diabetes mellitus: A review.2型糖尿病的肠道靶向治疗：综述
World J Clin Cases. 2024 Jan 6;12(1):1-8. doi: 10.12998/wjcc.v12.i1.1.
5
Probiotics as potential biotherapeutics in the management of type 2 diabetes - prospects and perspectives.益生菌作为 2 型糖尿病管理的潜在生物疗法——前景与展望。
Diabetes Metab Res Rev. 2013 Feb;29(2):103-12. doi: 10.1002/dmrr.2376.
6
Clinical study on sequential treatment of severe diarrhea irritable bowel syndrome with precision probiotic strains transplantation capsules, fecal microbiota transplantation capsules and live combined bacillus subtilis and enterococcus faecium capsules.严重腹泻型肠易激综合征患者进行精准益生菌菌株移植胶囊、粪便微生物群移植胶囊和枯草芽孢杆菌、肠球菌双联活菌胶囊序贯治疗的临床研究。
Front Cell Infect Microbiol. 2022 Sep 28;12:1025889. doi: 10.3389/fcimb.2022.1025889. eCollection 2022.
7
Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice.高脂饮食喂养的 C57BL/6J 小鼠中源自印度肠道的益生菌菌株对葡萄糖耐量和胰岛素敏感性的改善作用。
Eur J Nutr. 2018 Feb;57(1):279-295. doi: 10.1007/s00394-016-1317-7. Epub 2016 Oct 18.
8
Impacts of gut microbiota on gestational diabetes mellitus: a comprehensive review.肠道微生物群对妊娠期糖尿病的影响：全面综述。
Eur J Nutr. 2021 Aug;60(5):2343-2360. doi: 10.1007/s00394-021-02483-6. Epub 2021 Jan 29.
9
Probiotic reduces bacterial translocation in type 2 diabetes mellitus: A randomised controlled study.益生菌可减少 2 型糖尿病患者细菌易位：一项随机对照研究。
Sci Rep. 2017 Sep 21;7(1):12115. doi: 10.1038/s41598-017-12535-9.
10
Characteristics of the Gut Microbiota and Potential Effects of Probiotic Supplements in Individuals with Type 2 Diabetes .2型糖尿病患者肠道微生物群的特征及益生菌补充剂的潜在影响
Foods. 2021 Oct 21;10(11):2528. doi: 10.3390/foods10112528.

引用本文的文献

1
Beneficial effect of consuming milk containing only A2 beta-casein on gut microbiota: A single-center, randomized, double-blind, cross-over study.饮用仅含A2 β-酪蛋白的牛奶对肠道微生物群的有益作用：一项单中心、随机、双盲、交叉研究。
PLoS One. 2025 May 8;20(5):e0323016. doi: 10.1371/journal.pone.0323016. eCollection 2025.
2
Characteristics of elderly diabetes patients: focus on clinical manifestation, pathogenic mechanism, and the role of traditional Chinese medicine.老年糖尿病患者的特征：聚焦于临床表现、发病机制及中医药的作用
Front Pharmacol. 2024 Jan 11;14:1339744. doi: 10.3389/fphar.2023.1339744. eCollection 2023.
3

本文引用的文献

1
Probiotic Bacillus subtilis Protects against α-Synuclein Aggregation in C. elegans.枯草芽孢杆菌益生菌可预防线虫中α-突触核蛋白聚集。
Cell Rep. 2020 Jan 14;30(2):367-380.e7. doi: 10.1016/j.celrep.2019.12.078.
2
Alzheimer's Disease and Diabetes: Insulin Signaling as the Bridge Linking Two Pathologies.阿尔茨海默病与糖尿病：胰岛素信号作为连接两种病理的桥梁。
Mol Neurobiol. 2020 Apr;57(4):1966-1977. doi: 10.1007/s12035-019-01858-5. Epub 2020 Jan 3.
3
Bacillus Subtilis Delays Neurodegeneration and Behavioral Impairment in the Alzheimer's Disease Model Caenorhabditis Elegans.
Probiotic properties of DG101 isolated from the traditional Japanese fermented food nattō.
从传统日本发酵食品纳豆中分离出的DG101的益生菌特性。
Front Microbiol. 2023 Sep 28;14:1253480. doi: 10.3389/fmicb.2023.1253480. eCollection 2023.
4
Effects of the synbiotic composed of mangiferin and 1-12 on type 2 diabetes mellitus rats.芒果苷与1-12组成的合生元对2型糖尿病大鼠的影响。
Front Microbiol. 2023 Apr 20;14:1158652. doi: 10.3389/fmicb.2023.1158652. eCollection 2023.
5
Safety Evaluation and Anti-Inflammatory Efficacy of PS23.PS23 的安全性评估和抗炎功效。
Int J Mol Sci. 2022 Dec 31;24(1):724. doi: 10.3390/ijms24010724.
6
Metagenomic study of the gut microbiota associated with cow milk consumption in Chinese peri-/postmenopausal women.中国围绝经期/绝经后女性饮用牛奶相关肠道微生物群的宏基因组学研究。
Front Microbiol. 2022 Aug 16;13:957885. doi: 10.3389/fmicb.2022.957885. eCollection 2022.
7
Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.益生菌、益生元、合生元和后生元对靶向肠道微生物群的代谢性疾病的影响和作用机制：一种叙述性综述。
Nutrients. 2021 Sep 15;13(9):3211. doi: 10.3390/nu13093211.
枯草芽孢杆菌延缓阿尔茨海默病模型秀丽隐杆线虫的神经退行性变和行为损伤。
J Alzheimers Dis. 2020;73(3):1035-1052. doi: 10.3233/JAD-190837.
4
Bacterial Quorum Sensing and Microbial Community Interactions.细菌群体感应与微生物群落相互作用。
mBio. 2018 May 22;9(3):e02331-17. doi: 10.1128/mBio.02331-17.
5
Evaluation of probiotic and prebiotic-like effects of Bacillus subtilis BN on growth of lactobacilli.枯草芽孢杆菌BN对乳酸菌生长的益生菌及益生元样作用评估
J Gen Appl Microbiol. 2018 Mar 27;64(1):26-33. doi: 10.2323/jgam.2017.03.002. Epub 2017 Dec 8.
6
Microbial flora, probiotics, and the search for a long and healthy human longevity.微生物群落、益生菌与对人类长寿健康的探索。
Microb Cell. 2017 Mar 16;4(4):133-136. doi: 10.15698/mic2017.04.569.
7
Bacillus subtilis biofilm extends Caenorhabditis elegans longevity through downregulation of the insulin-like signalling pathway.枯草芽孢杆菌生物膜通过下调胰岛素样信号通路延长秀丽隐杆线虫的寿命。
Nat Commun. 2017 Jan 30;8:14332. doi: 10.1038/ncomms14332.
8
Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study.益生菌在 2 型糖尿病中的临床应用：一项随机、双盲、安慰剂对照研究。
Clin Nutr. 2017 Feb;36(1):85-92. doi: 10.1016/j.clnu.2015.11.011. Epub 2015 Dec 7.
9
Manipulating the gut microbiota to maintain health and treat disease.通过调控肠道微生物群来维持健康和治疗疾病。
Microb Ecol Health Dis. 2015 Feb 2;26:25877. doi: 10.3402/mehd.v26.25877. eCollection 2015.
10
The many faces of diabetes: a disease with increasing heterogeneity.糖尿病的多面性：一种具有日益异质性的疾病。
Lancet. 2014 Mar 22;383(9922):1084-94. doi: 10.1016/S0140-6736(13)62219-9. Epub 2013 Dec 3.